CLINICAL_TRIALS
trial_result
· 2014-06-03
Clinical Trial Update: GARDASIL™ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046) [Phase 3]
Summary
Phase 3 clinical trial update for GARDASIL in healthy females aged 9-26 in Sub-Saharan Africa, with completed status and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Papillomavirus Infections | Phase 3 | Status: COMPLETED | Results posted: 2014-06-03